Duke Royalty (DUKE); reports adjusted post tax profits of £1.83p per share for FY19
Dividend for the period was increased to 2.8p per share, up 33% YoY.
Duke Royalty announced its final results for the year ended 31 March 2019. Total income grew by 240% to £6.1m. Operational cash flow stood at of £4.1m for the period and adjusted post tax profits stood at £2.9m, 1.83p per share.
Read more...Henderson Far East Income (HFEL); allots 100,000 ordinary shares
Henderson Far East Income agreed on 2 September 2019 to allot 100,000 ordinary shares at 368p per share, each fully paid under its block listing facility. NAV per ordinary share as of 30 August 2019 was 358.9p.
Read more...KEFI Minerals (KEFI); issues 21,111,226 new ordinary shares of 0.1p each
Following admission of the 21,111,226 new ordinary shares, the total issued share capital of the company will consist of 744,831,278 ordinary shares
KEFI has received notice from one of its working capital providers to convert £175,000 of the Loan Note issued on 5 August 2019 and associated costs of £8,750 into new KEFI ordinary shares of 0.1p each at a price of 0.87p per share. Therefore, KEFI has allotted and issued 21,111,226 new KEFI ordinary shares of 0.1p each to the loan facility provider.
Read more...
PPHE Hotel Group; report total revenue increases 4.3%
PPHE has delivered another solid set of results with like-for-like EBITDA (excluding IFRS16) up 6% and like-for-like RevPAR up 8% which shows continued momentum from Q1. Progress was across the board although London looks arguably to have stolen the show outperforming a buoyant market (RevPar +5%). The company confirms an extensive £300m investment programme while as open and as patient as ever in terms of acquisitions
Read more...Target Healthcare REIT (THRL); non-pre-emptive placing of equity proposed
Under its existing Placing Programme, Target Healthcare will issue new ordinary shares at 110.5p per share at a 6.2% discount to the closing price on the last business day prior to the placing announcement. The issue price also represents a 2.8% premium to EPRA NAV for each ordinary share of 107.5 pence as of 30 June 2019.
Read more...HgCapital Trust (HGT); announces realisation in Register Group
The company will release the 30 June 2019 interim results on 9 September 2019.
HgCapital Trust announced a realisation in Register Group, a digital service provider for professionals. Register Group will be acquired by team.blue, a European digital enabler for companies.
Read more...Frontier Developments; reports FY results
Frontier reported EBITDA of £29m (FY18 £9.4m) and EPS of 45.4p (FY18 9.6p)
As was seen at the Interims, FY19 has seen a big step up for Frontier with revenues of £89m (FY18 £34.2m), reflecting the success of Jurassic World Evolution (2m units in 1st 7 months), which launched in June 2018 (FY19), on top of continuing sales from Elite Dangerous (2014) and Planet Coaster (2016).
Read more...Allied Minds; raises $51 million in Series C financing
Even excluding net cash, the NAV of these two portfolio companies comes to 57p, against a share price today of 59p
Allied Minds, the technology holding company, announced today $51m in Series C financing for one of its portfolio companies Federated Wireless, a player in Citizen Band Radio Service (CBRS), to accelerate its roll-out in the US.
Read more...BioPharma Credit (BPCR); report half-year results
Shares in issue stood at 1,373.9m.
BioPharma Credit announced its half-year report for the period ended 30 June 2019. The company invested a total of $165m during the period. Net assets for the period stood at $1,409.4m.
Read more...Oxford Biomedica (OXB); interim results: H1 2019 revenue down 9% YoY
Oxford Biomedica reported that its operating loss for the half stood at £1.4m vs operating profit of £9.4m in H1 2018. According to Oxford this was due to lower revenues and increased expenditure aimed at strengthening operation and strategic capacity. For the six months ended 30 June 2019, revenue from bioprocessing and commercial development was up 23% YoY.
Read more...